Hepatitis C Hepatitis C Liver biopsies are used to determine the degree of liver damage present; however, there are risks from the procedure.  The typical changes seen are lymphocytes within the parenchyma, lymphoid follicles in portal triad, and changes to the bile ducts.  There are a number of blood tests available that try to determine the degree of hepatic fibrosis and alleviate the need for biopsy. It is believed that only 5â€“50% of those infected in the United States and Canada are aware of their status.  Routine screening for those between the ages of 18 and 79 was recommended by the United States Preventive Services Task Force in 2020.  Previously, testing was recommended for those at high risk, including injection drug users, those who have received blood transfusions before 1992, those who have been incarcerated, those on long-term hemodialysis, and those with tattoos.  Screening is also recommended for those with elevated liver enzymes, as this is frequently the only sign of chronic hepatitis Hepatitis C Hepatitis C